Streetbeat News

Analyst Ratings

CNS

UBS analyst Adam Beatty has initiated coverage on Cohen & Steers (NYSE:CNS) with a Sell rating and set a price target of $68. This new coverage could influence investor sentiment and potentially impact CNS's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:19 pm

AXGN

ELAN

GBX

KRUS

The Greenbrier Companies, Inc. (NYSE:GBX) reported strong earnings, surpassing estimates with adjusted EPS of 96 cents against expected 73 cents. FY24 revenue is projected between $3.4 billion to $3.7 billion, compared to estimates of $3.58 billion. Greenbrier's shares jumped 13.8% to $50.50. Other stocks also moved higher, including AxoGen, Kura Sushi USA, Peloton Interactive, and Elanco Animal Health, following positive financial updates, upgrades, and executive announcements.

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 3:18 pm

TEAM

Oppenheimer has recommended buying Atlassian (TEAM) shares on the pullback, leading to an increase in the stock's trading price.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:16 pm

JHG

UBS analyst Adam Beatty has initiated coverage on Janus Henderson Group (NYSE:JHG) with a Sell rating and set a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:16 pm

FHI

UBS analyst Adam Beatty has initiated coverage on Federated Hermes (NYSE:FHI) with a Neutral rating and set a price target of $35.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:11 pm

ROIV

Piper Sandler analyst Allison Bratzel has initiated coverage on Roivant Sciences (NASDAQ:ROIV) with an Overweight rating and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:08 pm

SNOW

Snowflake Inc. shares have risen following an Outperform rating and $230 price target initiation by RBC Capital.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:05 pm

HIMS

Tigress Financial analyst Ivan Feinseth has reiterated a Buy rating on Hims & Hers Health (NYSE:HIMS) and increased the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:03 pm

FTRE

William Blair analyst Max Smock has initiated coverage on Fortrea Holdings (NASDAQ: FTRE) with a Market Perform rating. This new coverage could influence investor perception and potentially impact the stock's performance in the market.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 3:03 pm

MCRI

Monarch Casino & Resort (NASDAQ:MCRI) has been evaluated by 4 financial analysts over the past three months, with mixed opinions. The average 12-month price target is now $77.00, down from $93.00, with a high estimate of $90.00 and a low of $65.00. Analysts Jeffrey Stantial of Stifel and Barry Jonas of Truist Securities have both lowered their price targets. Monarch Casino & Resort's financial performance shows a slight revenue decline, an exceptional net margin, and strong ROE and ROA, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 3:01 pm